GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Lisheng Pharmaceutical Co Ltd (SZSE:002393) » Definitions » Net Income Including Noncontrolling Interests

Tianjin Lisheng Pharmaceutical Co (SZSE:002393) Net Income Including Noncontrolling Interests : ¥371 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Tianjin Lisheng Pharmaceutical Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Tianjin Lisheng Pharmaceutical Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was ¥56 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ¥371 Mil.

Tianjin Lisheng Pharmaceutical Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Tianjin Lisheng Pharmaceutical Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Lisheng Pharmaceutical Co Net Income Including Noncontrolling Interests Chart

Tianjin Lisheng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.14 8.62 122.11 93.61 361.83

Tianjin Lisheng Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.50 43.68 252.48 19.16 55.88

Tianjin Lisheng Pharmaceutical Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥371 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Lisheng Pharmaceutical Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Tianjin Lisheng Pharmaceutical Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Lisheng Pharmaceutical Co (SZSE:002393) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Lisheng Pharmaceutical Co Ltd (SZSE:002393) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
SZSE:300636 SHSE:600479 SHSE:603998 SHSE:603676 SZSE:002644 SHSE:688373 SZSE:300110 SZSE:301277 SHSE:600594 SHSE:688247 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No.491 Huanghe Street, Nankai, Tianjin, CHN, 300111
Website
http://www.lishengpharma.com
Tianjin Lisheng Pharmaceutical Co Ltd manufactures and sells tablet medicine, capsule medicine, pill, freeze-dry powder injection, liquid injection and raw material medicine.
Executives
Zhang Tong Sheng Director
Shi Xue Rong Supervisors
Zhao Yu Ming Director

Tianjin Lisheng Pharmaceutical Co (SZSE:002393) Headlines

No Headlines